The Food and Drug Administration today recommended medical device manufacturers, health care providers and patients take certain actions to reduce the risk that a remote attacker could exploit a set of cybersecurity vulnerabilities to control a medical device or prevent it from functioning. The agency to date has not received any adverse event reports associated with the vulnerabilities, announced in a July advisory from the Department of Homeland Security. The vulnerabilities exist in IPnet, a third-party software component that supports network communications between computers. The software is part of several operating systems and may be used in a wide range of medical and industrial devices.
 

Related News Articles

Headline
The AHA Oct. 6 released a Cybersecurity Advisory urging immediate action against a critical Oracle E-Business Suite vulnerability that is remotely exploitable…
Headline
The AHA has launched an enhanced Cybersecurity and Risk webpage designed to help health care organizations strengthen their defenses against emerging cyber and…
Headline
A Health-ISAC (Information Sharing and Analysis Center) bulletin released Oct. 1 warns of a recently released LockBit 5.0 ransomware variant that poses a…
Headline
Fernando Martinez, Ph.D., chief digital officer at the Texas Hospital Association, shares how Texas and the THA are building regional resilience through cyber…
Headline
The federal government shut down Oct. 1 following a failed Senate vote on the House-passed continuing resolution to fund the government by midnight Sept. 30.…
Headline
The Food and Drug Administration yesterday announced that Olympus issued a global recall of its ViziShot 2 FLEX needles manufactured prior to May 12 following…